APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine Enteric Coated Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mesalazine Enteric Coated Tablets Market Outlook and Growth Opportunities 2026

27 December 2025197 pages

Choose your research edition.

Industry ResearchMesalazine Enteric Coated Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Enteric Coated Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Mesalazine Enteric Coated Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Enteric Coated Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Enteric Coated Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Mesalazine Enteric Coated Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mesalazine Enteric Coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mesalazine Enteric Coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalazine Enteric Coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mesalazine Enteric Coated Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mesalazine Enteric Coated Tablets market include CR Sanjiu, Huahai Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Fosun Pharma, DSM Pharmaceuticals, Dr. Falk Pharma GmbH, Astellas Pharma Inc. and AbbVie Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mesalazine Enteric Coated Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalazine Enteric Coated Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalazine Enteric Coated Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalazine Enteric Coated Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalazine Enteric Coated Tablets Segment by Company

CR Sanjiu

Huahai Pharmaceuticals

UCB Pharma

Sun Pharmaceutical Industries Ltd.

Fosun Pharma

DSM Pharmaceuticals

Dr. Falk Pharma GmbH

Astellas Pharma Inc.

AbbVie Inc.

Mesalazine Enteric Coated Tablets Segment by Type

0.25g

0.5g

1g

Mesalazine Enteric Coated Tablets Segment by Application

Hospital

Clinic

Others

Mesalazine Enteric Coated Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mesalazine Enteric Coated Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mesalazine Enteric Coated Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mesalazine Enteric Coated Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Mesalazine Enteric Coated Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine Enteric Coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine Enteric Coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine Enteric Coated Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalazine Enteric Coated Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalazine Enteric Coated Tablets industry.

Chapter 3: Detailed analysis of Mesalazine Enteric Coated Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mesalazine Enteric Coated Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mesalazine Enteric Coated Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mesalazine Enteric Coated Tablets Industry Trends Table 2. Mesalazine Enteric Coated Tablets Industry Drivers Table 3. Mesalazine Enteric Coated Tablets Industry Opportunities and Challenges Table 4. Mesalazine Enteric Coated Tablets Industry Restraints Table 5. Global Mesalazine Enteric Coated Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mesalazine Enteric Coated Tablets Revenue Share by Company (2021-2026) Table 7. Global Mesalazine Enteric Coated Tablets Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Mesalazine Enteric Coated Tablets Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Mesalazine Enteric Coated Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mesalazine Enteric Coated Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Mesalazine Enteric Coated Tablets Company, Product Type & Application Table 13. Global Mesalazine Enteric Coated Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalazine Enteric Coated Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.25g Table 18. Significant Companies of 0.5g Table 19. Significant Companies of 1g Table 20. Global Mesalazine Enteric Coated Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Mesalazine Enteric Coated Tablets Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Mesalazine Enteric Coated Tablets Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Mesalazine Enteric Coated Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mesalazine Enteric Coated Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Mesalazine Enteric Coated Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Mesalazine Enteric Coated Tablets Sales Value Share by Type (2021-2026) Table 29. Global Mesalazine Enteric Coated Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Mesalazine Enteric Coated Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Mesalazine Enteric Coated Tablets Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Mesalazine Enteric Coated Tablets Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Mesalazine Enteric Coated Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Mesalazine Enteric Coated Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Mesalazine Enteric Coated Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Mesalazine Enteric Coated Tablets Sales Value Share by Application (2021-2026) Table 42. Global Mesalazine Enteric Coated Tablets Sales Value Share by Application (2027-2032) Table 43. Global Mesalazine Enteric Coated Tablets Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Mesalazine Enteric Coated Tablets Sales by Region (2021-2026) & (Tons) Table 45. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2026) Table 46. Global Mesalazine Enteric Coated Tablets Sales by Region (2027-2032) & (Tons) Table 47. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2027-2032) Table 48. Global Mesalazine Enteric Coated Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Mesalazine Enteric Coated Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Mesalazine Enteric Coated Tablets Sales Value Share by Region (2021-2026) Table 51. Global Mesalazine Enteric Coated Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Mesalazine Enteric Coated Tablets Sales Value Share by Region (2027-2032) Table 53. Global Mesalazine Enteric Coated Tablets Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Mesalazine Enteric Coated Tablets Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Mesalazine Enteric Coated Tablets Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Mesalazine Enteric Coated Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons) Table 58. Global Mesalazine Enteric Coated Tablets Sales Market Share by Country (2021-2026) Table 59. Global Mesalazine Enteric Coated Tablets Sales by Country (2027-2032) & (Tons) Table 60. Global Mesalazine Enteric Coated Tablets Sales Market Share by Country (2027-2032) Table 61. Global Mesalazine Enteric Coated Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Mesalazine Enteric Coated Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Mesalazine Enteric Coated Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Mesalazine Enteric Coated Tablets Sales Value Market Share by Country (2027-2032) Table 65. CR Sanjiu Company Information Table 66. CR Sanjiu Business Overview Table 67. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio Table 69. CR Sanjiu Recent Development Table 70. Huahai Pharmaceuticals Company Information Table 71. Huahai Pharmaceuticals Business Overview Table 72. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio Table 74. Huahai Pharmaceuticals Recent Development Table 75. UCB Pharma Company Information Table 76. UCB Pharma Business Overview Table 77. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio Table 79. UCB Pharma Recent Development Table 80. Sun Pharmaceutical Industries Ltd. Company Information Table 81. Sun Pharmaceutical Industries Ltd. Business Overview Table 82. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio Table 84. Sun Pharmaceutical Industries Ltd. Recent Development Table 85. Fosun Pharma Company Information Table 86. Fosun Pharma Business Overview Table 87. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio Table 89. Fosun Pharma Recent Development Table 90. DSM Pharmaceuticals Company Information Table 91. DSM Pharmaceuticals Business Overview Table 92. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio Table 94. DSM Pharmaceuticals Recent Development Table 95. Dr. Falk Pharma GmbH Company Information Table 96. Dr. Falk Pharma GmbH Business Overview Table 97. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio Table 99. Dr. Falk Pharma GmbH Recent Development Table 100. Astellas Pharma Inc. Company Information Table 101. Astellas Pharma Inc. Business Overview Table 102. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio Table 104. Astellas Pharma Inc. Recent Development Table 105. AbbVie Inc. Company Information Table 106. AbbVie Inc. Business Overview Table 107. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio Table 109. AbbVie Inc. Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Mesalazine Enteric Coated Tablets Distributors List Table 113. Mesalazine Enteric Coated Tablets Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Mesalazine Enteric Coated Tablets Product Image Figure 2. Global Mesalazine Enteric Coated Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mesalazine Enteric Coated Tablets Sales (2021-2032) & (Tons) Figure 5. Global Mesalazine Enteric Coated Tablets Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Mesalazine Enteric Coated Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.25g Image Figure 10. 0.5g Image Figure 11. 1g Image Figure 12. Global Mesalazine Enteric Coated Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Mesalazine Enteric Coated Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Mesalazine Enteric Coated Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mesalazine Enteric Coated Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalazine Enteric Coated Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Mesalazine Enteric Coated Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Mesalazine Enteric Coated Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Mesalazine Enteric Coated Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Mesalazine Enteric Coated Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Mesalazine Enteric Coated Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalazine Enteric Coated Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Mesalazine Enteric Coated Tablets Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Mesalazine Enteric Coated Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Mesalazine Enteric Coated Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Mesalazine Enteric Coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Mesalazine Enteric Coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Mesalazine Enteric Coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Mesalazine Enteric Coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Mesalazine Enteric Coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Mesalazine Enteric Coated Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Mesalazine Enteric Coated Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • CR Sanjiu
  • Huahai Pharmaceuticals
  • UCB Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Fosun Pharma
  • DSM Pharmaceuticals
  • Dr. Falk Pharma GmbH
  • Astellas Pharma Inc.
  • AbbVie Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Mesalazine Enteric Coated Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Mesalazine Enteric Coated Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mesalazine Enteric Coated Tablets Market Dynamics
  1. 2.1 Mesalazine Enteric Coated Tablets Industry Trends
  2. 2.2 Mesalazine Enteric Coated Tablets Industry Drivers
  3. 2.3 Mesalazine Enteric Coated Tablets Industry Opportunities and Challenges
  4. 2.4 Mesalazine Enteric Coated Tablets Industry Restraints
3 Mesalazine Enteric Coated Tablets Market by Company
  1. 3.1 Global Mesalazine Enteric Coated Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Mesalazine Enteric Coated Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Mesalazine Enteric Coated Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Mesalazine Enteric Coated Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Mesalazine Enteric Coated Tablets Company Ranking (2024-2026)
  6. 3.6 Global Mesalazine Enteric Coated Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Mesalazine Enteric Coated Tablets Company Product Type and Application
  8. 3.8 Global Mesalazine Enteric Coated Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mesalazine Enteric Coated Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mesalazine Enteric Coated Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mesalazine Enteric Coated Tablets Market by Type
  1. 4.1 Mesalazine Enteric Coated Tablets Type Introduction
  2. 4.1.1 0.25g
  3. 4.1.2 0.5g
  4. 4.1.3 1g
  5. 4.2 Global Mesalazine Enteric Coated Tablets Sales Volume by Type
  6. 4.2.1 Global Mesalazine Enteric Coated Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalazine Enteric Coated Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Mesalazine Enteric Coated Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Mesalazine Enteric Coated Tablets Sales Value by Type
  10. 4.3.1 Global Mesalazine Enteric Coated Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalazine Enteric Coated Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Mesalazine Enteric Coated Tablets Sales Value Share by Type (2021-2032)
5 Mesalazine Enteric Coated Tablets Market by Application
  1. 5.1 Mesalazine Enteric Coated Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Mesalazine Enteric Coated Tablets Sales Volume by Application
  6. 5.2.1 Global Mesalazine Enteric Coated Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mesalazine Enteric Coated Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mesalazine Enteric Coated Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mesalazine Enteric Coated Tablets Sales Value by Application
  10. 5.3.1 Global Mesalazine Enteric Coated Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mesalazine Enteric Coated Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mesalazine Enteric Coated Tablets Sales Value Share by Application (2021-2032)
6 Mesalazine Enteric Coated Tablets Regional Sales and Value Analysis
  1. 6.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalazine Enteric Coated Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Mesalazine Enteric Coated Tablets Sales by Region (2027-2032)
  5. 6.3 Global Mesalazine Enteric Coated Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mesalazine Enteric Coated Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mesalazine Enteric Coated Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mesalazine Enteric Coated Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Mesalazine Enteric Coated Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Mesalazine Enteric Coated Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Mesalazine Enteric Coated Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mesalazine Enteric Coated Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Mesalazine Enteric Coated Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Value Share by Country, 2025 VS 2032
7 Mesalazine Enteric Coated Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Mesalazine Enteric Coated Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalazine Enteric Coated Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mesalazine Enteric Coated Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Mesalazine Enteric Coated Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Mesalazine Enteric Coated Tablets Sales by Country (2027-2032)
  6. 7.4 Global Mesalazine Enteric Coated Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mesalazine Enteric Coated Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mesalazine Enteric Coated Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mesalazine Enteric Coated Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mesalazine Enteric Coated Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mesalazine Enteric Coated Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CR Sanjiu
  2. 8.1.1 CR Sanjiu Company Information
  3. 8.1.2 CR Sanjiu Business Overview
  4. 8.1.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio
  6. 8.1.5 CR Sanjiu Recent Developments
  7. 8.2 Huahai Pharmaceuticals
  8. 8.2.1 Huahai Pharmaceuticals Company Information
  9. 8.2.2 Huahai Pharmaceuticals Business Overview
  10. 8.2.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
  12. 8.2.5 Huahai Pharmaceuticals Recent Developments
  13. 8.3 UCB Pharma
  14. 8.3.1 UCB Pharma Company Information
  15. 8.3.2 UCB Pharma Business Overview
  16. 8.3.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio
  18. 8.3.5 UCB Pharma Recent Developments
  19. 8.4 Sun Pharmaceutical Industries Ltd.
  20. 8.4.1 Sun Pharmaceutical Industries Ltd. Company Information
  21. 8.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
  22. 8.4.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  25. 8.5 Fosun Pharma
  26. 8.5.1 Fosun Pharma Company Information
  27. 8.5.2 Fosun Pharma Business Overview
  28. 8.5.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio
  30. 8.5.5 Fosun Pharma Recent Developments
  31. 8.6 DSM Pharmaceuticals
  32. 8.6.1 DSM Pharmaceuticals Company Information
  33. 8.6.2 DSM Pharmaceuticals Business Overview
  34. 8.6.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
  36. 8.6.5 DSM Pharmaceuticals Recent Developments
  37. 8.7 Dr. Falk Pharma GmbH
  38. 8.7.1 Dr. Falk Pharma GmbH Company Information
  39. 8.7.2 Dr. Falk Pharma GmbH Business Overview
  40. 8.7.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio
  42. 8.7.5 Dr. Falk Pharma GmbH Recent Developments
  43. 8.8 Astellas Pharma Inc.
  44. 8.8.1 Astellas Pharma Inc. Company Information
  45. 8.8.2 Astellas Pharma Inc. Business Overview
  46. 8.8.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio
  48. 8.8.5 Astellas Pharma Inc. Recent Developments
  49. 8.9 AbbVie Inc.
  50. 8.9.1 AbbVie Inc. Company Information
  51. 8.9.2 AbbVie Inc. Business Overview
  52. 8.9.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio
  54. 8.9.5 AbbVie Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalazine Enteric Coated Tablets Value Chain Analysis
  2. 9.1.1 Mesalazine Enteric Coated Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalazine Enteric Coated Tablets Sales Mode & Process
  6. 9.2 Mesalazine Enteric Coated Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalazine Enteric Coated Tablets Distributors
  9. 9.2.3 Mesalazine Enteric Coated Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst